Nurse Practitioner, Family · Honolulu, HI
NPI
1881131563
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2828 Paa St
Honolulu, HI, 96819
Phone (808) 432-2000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$281K
1,683 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Karen Badiable prescribed most often to Medicare patients was Insulin Glargine-Yfgn, with 158 prescriptions and refills. In total Karen Badiable wrote 1,683 Medicare prescriptions that cost $281K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-10.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Insulin Glargine-Yfgn Generic | 158 | 414 | 105 | $22K |
| Humulin N Insulin Nph Human Isophane | 137 | 337 | 70 | $20K |
| Losartan Potassium Generic | 112 | 336 | 56 | $1,583 |
| Amlodipine Besylate Generic | 111 | 323 | 54 | $1,517 |
| Jardiance Empagliflozin | 82 | 196 | 26 | $32K |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 77 | 77 | 77 | $1,736 |
| Lisinopril Generic | 73 | 208 | 38 | $967 |
| Glipizide Generic | 69 | 204 | 33 | $798 |
| Metformin Hcl Er Metformin Hcl | 67 | 194 | 38 | $616 |
| Metformin Hcl Generic | 59 | 160 | 25 | $717 |
| Liraglutide Generic | 55 | 56 | 17 | $37K |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 53 | 101 | 18 | $715 |
| Glipizide Er Glipizide | 51 | 148 | 26 | $1,703 |
| Humulin R Insulin Regular, Human | 48 | 124 | 25 | $6,949 |
| Ozempic Semaglutide | 45 | 47 | 17 | $33K |
Brand drugs: 678 claims; generic drugs: 899 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Karen Badiable were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.